文献速递神经免疫

多发性硬化免疫病理亚型的临床相关性

Clinical Correlation of Multiple Sclerosis Immunopathologic Subtypes.
PubMed 文献 · Neurology · 2021-09-09

该研究对547例活检或尸检确诊的中枢神经系统脱髓鞘患者进行免疫病理分型,比较各亚型临床特征。结果显示模式I占23%、模式II占56%、模式III占22%;模式III初次发作残疾更重且单相病程更常见,但长期生存无差异,进展性疾病与初始免疫模式关联较弱。

要点

  • 模式III首次发作残疾更重(EDSS中位数4 vs 3)。
  • 模式III单相病程更常见(59% vs 33% vs 32%)。
  • 各免疫模式长期生存无差异,进展性疾病与初始模式关联弱。

核心结论

  • 三种免疫模式均可在活动性病灶中检测到,但疾病后期因活动性病灶减少而检出频率降低。
  • 模式III与比模式I或II更暴发的首次发作相关,但活检患者长期结局在各免疫模式间相似。
  • 进展性疾病与初始免疫模式关联较弱,提示可能汇入与慢性脱髓鞘轴索相关的最终共同通路。

研究设计与样本

  • 对547例活检或尸检确诊的中枢神经系统脱髓鞘患者标本进行免疫病理分型。
  • 比较各免疫病理亚型患者的临床特征,中位随访时间2.3年(范围0-38年)。

主要发现

  • 免疫病理亚型频率:模式I占23%,模式II占56%,模式III占22%。
  • 各免疫模式在尸检/活检时年龄(中位41岁,范围4-83岁,p=0.16)和女性比例(54%,p=0.71)相似。
  • 模式III在尸检病例中占比更高(45% vs 活检队列19%,p<0.001)。
  • 模式III与模式II相比,首次发作相关残疾更重(EDSS中位数4 vs 3,p=0.02)。
  • 单相临床病程在模式III中更常见(59% vs 模式I 33% vs 模式II 32%,p<0.001)。

临床怎么用

  • 活检或尸检证实的免疫病理模式有助于理解首次发作的严重程度,模式III提示更暴发的起病。
  • 长期结局在各免疫模式间相似,进展性疾病与初始模式关联弱,临床决策需综合评估。

局限性

  • 免疫模式在疾病后期因活动性病灶减少而检出频率降低,可能影响分型代表性。
  • 进展性疾病分析样本量有限(总体p=0.49),需谨慎解读。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: The goal of this work was to compare clinical characteristics across immunopathologic subtypes of patients with multiple sclerosis. METHODS: Immunopathologic subtyping was performed on specimens from 547 patients with biopsy- or autopsy-confirmed CNS demyelination. RESULTS: The frequency of immunopathologic subtypes was 23% for pattern I, 56% for pattern II, and 22% for pattern III. Immunopatterns were similar in terms of age at autopsy/biopsy (median age 41 years, range 4-83 years, p = 0.16) and proportion female (54%, p = 0.71). Median follow-up after symptom onset was 2.3 years (range 0-38 years). In addition to being overrepresented among autopsy cases (45% vs 19% in biopsy cohort, p < 0.001), index attack-related disability was higher in pattern III vs II (median Expanded Disability Status Scale score 4 vs 3, p = 0.02). Monophasic clinical course was more common in patients with pattern III than pattern I or II (59% vs 33% vs 32%, p < 0.001). Similarly, patients with pattern III pathology were likely to have progressive disease compared to patients with patterns I or II when followed up for ≥5 years (24% overall, p = 0.49), with no differences in long-term survival, despite a more fulminant attack presentation. CONCLUSION: All 3 immunopatterns can be detected in active lesions, although they are found less frequently later into the disease due to the lower number of active lesions. Pattern III is associated with a more fulminant initial attack than either pattern I or II. Biopsied patients appear to have similar long-term outcomes regardless of their immunopatterns. Progressive disease is less associated with the initial immunopattern and suggests convergence into a final common pathway related to the chronically denuded axon.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Tobin WO, Kalinowska-Lyszczarz A, Weigand SD, et al. Clinical Correlation of Multiple Sclerosis Immunopathologic Subtypes. Neurology. 2021. PMID: 34504026. doi:10.1212/WNL.0000000000012782

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。